ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

PPIL1 promotes hepatocellular carcinoma progression and associates with poor prognosis.

Yunyu Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.